Showing 421 - 440 results of 27,198 for search '(( 50 ((mg decrease) OR (mean decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 0.73s Refine Results
  1. 421
  2. 422

    Zinc exposure decreases NR1 clusters and NMDA currents. by Jia Zhu (135506)

    Published 2012
    “…Scale bar, 50 µm. (B) and (C) show the quantification of (A). …”
  3. 423
  4. 424
  5. 425
  6. 426
  7. 427
  8. 428
  9. 429

    Decreased oxidative phosphorylation in SDH and VHL-related PH/PGL. by Judith Favier (78711)

    Published 2013
    “…(D–F) Mean values for mitochondrial complexes II+III, III and IV reveal a generalized decrease in respiration in SDH and VHL PH/PGL. …”
  10. 430
  11. 431

    ROCK inhibition decreases the motility of MHCC97H cells. by Ji-Gang Zhang (278184)

    Published 2014
    “…(<b>B</b>) and (<b>D</b>) Data were normalized to untreated cells and the relative migration or invasion is expressed as mean ± S.E. of triplicate experiments. Fewer cells migrated or invaded 48 h after incubation with Y27632 (50 µM), compared with the control cells, *<i>P</i><0.05, **<i>P</i><0.01 and ***<i>P</i><0.001.…”
  12. 432

    ATRA decreased α-SMA expression in LT and HT cultures. by Carmen Retana (479628)

    Published 2013
    “…<p>(<b>A</b>) Immunofluorescence of omentum-derived mesothelial cells (control) and effluent-derived mesothelial cells from LT and HT grown until confluence in the presence of ATRA (0, 50 and 100 nM). …”
  13. 433
  14. 434
  15. 435
  16. 436
  17. 437
  18. 438

    Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

    Published 2022
    “…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”
  19. 439

    Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

    Published 2022
    “…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”
  20. 440

    IC<sub>50</sub> is distinct for diclofenac, ibuprofen, and ASA. by Verena Leidgens (815986)

    Published 2015
    “…The assays showed a significant linear concentration-dependent decrease of cell viability, which significantly differed between (A) ibuprofen (IC<sub>50</sub>, 1 mM) and (B) diclofenac (IC<sub>50</sub>, 0.1 mM). …”